Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients

NCT05649280 is registered in ClinicalTrials.gov with Soutien aux Actions contre les Maladies du Globule Rouge as lead sponsor.

NCT NCT05649280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients
Lead sponsor
Soutien aux Actions contre les Maladies du Globule Rouge
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
June 1, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease